TEIJIN launches the tissue engineering business for bone/cartilage-related tissues by utilizing nanotechnology by 2020. October,2012
【Supercategory：6. Products Subcategory：6.1 New products of 2013】
TEIJIN launches the tissue engineering business by utilizing nanotechnology.
TEIJIN commercializes the technology to accelerate regeneration of bone/cartilage by fixing the chipped part with composite nanofiber of bioabsorbable polymer with medical agent. TEIJIN enforces the R & D of the next-generation medical materials to be applied in the conventional medical treatment in order to enhance its efficiency, and accelerates the practical application as a main driving force in the health care business.
JCFA News Letter (No.3) October, 2012/Japan Chemical Fibers Association
TEIJIN commercializes the technology to accelerate regeneration of bone/cartilage by fixing the chipped part with composite nanofiber of bioabsorbable polymer with medical agent. TEIJIN enforces the R & D of the next-generation medical materials to be applied in the conventional medical treatment in order to enhance its efficiency, and accelerates the practical application as a main driving force in the health care business.
JCFA News Letter (No.3) October, 2012/Japan Chemical Fibers Association
| Researcher | TEIJIN |
|---|---|
| University or institution | TEIJIN |
Keywords